CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-18). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2847 · Search date 2026-08-18 · Methodology v0.7

One additional hyperbaric-oxygen session after a standard first session,
does it really help with Increased complete recovery at one month after acute carbon monoxide poisoning with initial coma?

30-Second Summary
D
Evidence Grade D · 30 · Safety warning
Adding a second hyperbaric-oxygen session after initial coma reduced one-month complete recovery
Trial B found a 21-point lower complete-recovery rate with the additional session. Claustrophobia, ear pain, seizure, and confirmed barotrauma also occurred, making this a clinically relevant harm signal.
What the
research shows
The grade is D. In trial B, which randomized 206 patients with initial coma, complete recovery occurred in 42/90 (47%) assessed after two sessions versus 54/80 (68%) after one. The odds ratio for recovery with the extra session was 0.42, 95% CI 0.23 to 0.79. This was not merely null: the additional-session group did significantly worse.
What the
ads claim
Carbon monoxide exposure from briquettes, vehicle exhaust, and fires makes hyperbaric treatment a real emergency-medicine debate in Korea. This verdict does not reject hyperbaric oxygen as a whole; it addresses adding a second session after the first in initially comatose patients.
*

Useful facts when choosing a product

  • The absolute complete-recovery difference was 21 points lower with the additional session.
  • Sessions stopped for four cases of claustrophobia, two of ear pain, and one seizure; barotrauma was confirmed in six patients.
  • Verdict 1249 is D with 20 points for aging markers, and verdict 1809 is D with 30 points for post-concussion syndrome; both concern different indications.
Gap Measurement · Verdict 2847 · D 30
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

One paper reported two randomized trials run by the same investigators, hospital, and Assistance Publique des Hopitaux de Paris support. The evidence array combines them in one item and lists trial A as NCT01100515 and trial B as NCT01099995. Trial A randomized 179 participants to normobaric oxygen or one hyperbaric session; trial B randomized 206 to one or two sessions. Trial B compared adding a second session after the standard single hyperbaric-oxygen session with not adding a second session. They were not counted as independent replication. A neurologically qualified intensivist blinded to allocation performed most one-month examinations, but general practitioners assessed those unable to return and the patient questionnaire was unblinded. Limitation name: complete-case analysis. Listed item: complete-case analysis - 170 of 206 trial B participants were in the observed primary result. Avoidability: avoidable - prespecified multiple imputation or an all-randomized primary analysis could have been used. Limitation name: substantial attrition. Listed item: attrition at least 15% - 36/206, 17.5%, in trial B; trial A was 26/179, 14.5%, and did not meet the threshold. Avoidability: avoidable - telephone and visit follow-up could have reduced one-month missingness. Limitation name: early stopping. Listed item: early stopping at interim analysis - the planned 970 participants stopped at 385 for harm in trial B and futility in trial A. Avoidability: unavoidable - continuing extra-session allocation after worse recovery emerged would have been unsafe. Limitation name: unblinded subjective endpoint. Listed item: unblinded subjective endpoint - self-report and some general-practitioner judgment contributed. Avoidability: avoidable - sham chamber sessions and centralized blinded assessment were feasible.

02

Why this is classified as D (30)

A publicly funded randomized trial found significantly worse complete recovery with an extra session, but one research program with complete-case analysis, 17.5% attrition, interim stopping, and partial unblinding gives D with 30 points.

Counterpoint. This trial excludes benefit from the extra session studied, but it does not establish the answer for different pressures, schedules, or patients without initial coma.

Rejudgment record. Cross-check applied — The initially comatose trial found significantly worse complete recovery with an extra session, while complete-case analysis, 17.5% attrition, interim stopping, and a single program limit certainty

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE-Harm increased in the trials
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Complete-recovery benefit from a second hyperbaric session after initial comaDComplete recovery was significantly worse with the extra session, 47% versus 68%.
Benefit of one hyperbaric session versus normobaric oxygen after transient loss of consciousnessDThe result was null at 58% versus 61%, OR 0.90, 95% CI 0.47 to 1.71, leaving substantial benefit possible.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Two prospective parallel randomized trials within one research program, using numbered sealed envelopes and independently generated sequences170Supported by Assistance Publique des Hopitaux de Paris, with no sponsor role in design, collection, analysis, publication, or writingComplete recovery at one month: no self-reported symptoms plus normal physical examination and normal neuropsychological functionsTrial A 58% versus 61%, OR 0.90, 95% CI 0.47 to 1.71; trial B two versus one session 47% versus 68%, OR 0.42, 95% CI 0.23 to 0.79, absolute difference -21 pointsOne evidence item combining two trials from one program; trial B is pivotal for the extra-session question
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-18).

Annane D, Chadda K, Gajdos P, Jars-Guincestre MC, Chevret S, Raphael JC. Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Med. 2011;37(3):486-492. PMID: 21125215. DOI: 10.1007/s00134-010-2093-0.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-18 · Corrections: none

Cite this verdict

One Additional Hyperbaric-Oxygen Session Is Ineffective for 1-Month Complete Recovery After Acute Carbon Monoxide Poisoning - No Benefit Evidence Grade D card
[Chamgap] One Additional Hyperbaric-Oxygen Session Is Ineffective for 1-Month Complete Recovery After Acute Carbon Monoxide Poisoning - No Benefit — Evidence Grade D·30. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/general/additional-hyperbaric-oxygen-acute-carbon-monoxide-poisoning-complete-recovery/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.